NYMC > News and Events > NYMC in the News

Sickle Cell Disease: Overview and Emerging Stem Cell Transplant Therapy

December 15, 2018

Mitchell S. Cairo, M.D.Mitchell Cairo, MD, Chief of Pediatric Hematology, Oncology and Stem Cell Transplantation at New York Medical College discusses his study at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego. Sickle cell disease is a group of inherited red blood cells disorders.

Mitchell S. Cairo, M.D., professor of pediatrics, division of pediatric hematology, oncology and stem cell transplantation, and professor of medicine, pathology, microbiology and immunology, and cell biology and anatomy

Source: Check Rate